Non-vitamin K Oral Anticoagulation
Showing 1 - 25 of >10,000
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))
Recruiting
- AORTIC VALVE DISEASES
- Thromboembolism
- Rivaroxaban Oral Tablet
- Vitamin K antagonist(warfarin)
-
Bucheon, Korea, Republic of
- +8 more
Oct 11, 2022
Oral Anticoagulation Drugs and How Well These Drugs Work in Real
Active, not recruiting
- Atrial Fibrillation
- Rivaroxaban (Xarelto)
- +3 more
-
Multiple Locations, SwedenMany locations
Jan 20, 2023
Stroke, Atrial Fibrillation Trial in Canada, Denmark (Investigators can choose from one of four Non-vitamin K oral
Recruiting
- Stroke
- Atrial Fibrillation
- Non-vitamin K oral anticoagulant (NOAC)
-
Concord, New South Wales, Australia
- +46 more
Oct 21, 2022
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments
Completed
- Hemophilia A
- +2 more
- Vitamin K Antagonist - Drug
-
Brest, France
- +5 more
Apr 6, 2023
Different Antithrombotic Therapy for Treatment of Ventricular
Recruiting
- Ventricular Thrombus
- non-vitamin K antagonist oral anticoagulants (NOACs)
- +3 more
-
Beijing, ChinaQing Yang
Jul 11, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
NOACs Use in AF or VTE (SUNSHINE Registry)
Recruiting
- Atrial Fibrillation
- +2 more
- Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jun 6, 2022
Atrial Fibrillation Patients With Intermediate Stroke Risk Trial in Seoul (Anticoagulation group(Apixaban group))
Recruiting
- Atrial Fibrillation Patients With Intermediate Stroke Risk
- Anticoagulation group(Apixaban group)
-
Seoul, Korea, Republic ofSeverance Cardiovascular Hospital Yonsei University
Aug 11, 2020
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Acute Ischemic Stroke, Atrial Fibrillation, Stenosis, Carotid Trial (Anticoagulant Oral, Anticoagulation combined with
Not yet recruiting
- Acute Ischemic Stroke
- +3 more
- Anticoagulant Oral
- Anticoagulation combined with antiplatelet therapy
- (no location specified)
Sep 21, 2023
Non-vitamin K Antagonist Oral Anticoagulant Concentration and
Recruiting
- Atrial Fibrillation
- Data collection
-
Taipei, Please Select, Taiwan
- +1 more
Apr 17, 2022
Atrial Fibrillation Trial (Non-vitamin K oral anticoagulants (NOACs), Warfarin)
Not yet recruiting
- Atrial Fibrillation
- Non-vitamin K oral anticoagulants (NOACs)
- Warfarin
- (no location specified)
Aug 6, 2021
Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)
Completed
- Intracerebral Hemorrhage
- Tranexamic acid
- Saline 0.9%
-
Basel, SwitzerlandStroke Center, University Hospital Basel
Mar 22, 2022
Diabetes Type 2 With Periodontal Disease Trial in Kirikkale (Vitamin D3K2, Saline Solution)
Completed
- Diabetes Mellitus Type 2 With Periodontal Disease
- Vitamin D3K2
- Saline Solution
-
Kırıkkale, TurkeyKirikkale University
Oct 5, 2023
Atrial Fibrillation, End-stage Kidney Disease Trial in Münster (Apixaban, Phenprocoumon)
Recruiting
- Atrial Fibrillation
- End-stage Kidney Disease
-
Münster, GermanyUniversitätsklinikum Münster
Apr 26, 2021
Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute
Recruiting
- Therapeutic Drug Monitoring
- Blood sampling to test drug level
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 8, 2022
Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Completed
- Ischemic Stroke
- +4 more
- not applicable (observational study)
-
Heidelberg, GermanyUniversity Hospital Heidelberg
Nov 1, 2022
Benign Prostatic Hyperplasia, Anticoagulant Adverse Reaction Trial in Toulouse (Maintenance of OAC in surgery of BPH by PVP.,
Recruiting
- Benign Prostatic Hyperplasia
- Anticoagulant Adverse Reaction
- Maintenance of OAC in surgery of BPH by PVP.
- Discontinuation of OAC in surgery of BPH by PVP.
-
Toulouse, FranceClinique Pasteur
Oct 19, 2022
Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Netherlands (Left atrial appendage occlusion (Watchman FLX
Recruiting
- Atrial Fibrillation
- Anticoagulants and Bleeding Disorders
- Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
-
Leeuwarden, Friesland, Netherlands
- +13 more
Dec 19, 2022
Kidney Failure, Chronic Trial in France (No oral anticoagulation, Oral anticoagulation with vitamin K antagonists)
Recruiting
- Kidney Failure, Chronic
- No oral anticoagulation
- Oral anticoagulation with vitamin K antagonists
-
Amiens, France
- +24 more
Sep 13, 2021
Anticoagulants in Patients With Venous Thromboembolism in Korea
Completed
- Venous Thromboembolism
- Parenteral anticoagulant
- +5 more
-
Seongnam-si, Korea, Republic of
- +1 more
May 20, 2022